| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |